These upcoming presentations underscore the breadth and versatility of our ACT-UP1 platform,” said Xuehai Liang, Ph.D., Chief Executive Officer of Arnatar Therapeutics. “By demonstrating the ability ...

In vivo studies demonstrate robust and durable gene silencing across rodents and non-human primates Megalin-targeting ligand-siRNA conjugates ...

London will become the global spotlight for cell and gene therapy (CGT) this November as Nobel Laureate, scientific leaders, biotech innovators, and top investors convene to chart the future of one of ...

A defined, xeno-free culture medium from Takara Bio Europe is opening new possibilities for large-scale production of ...

An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice ...

Researchers identify FGFR4, FLT1, and WNT5A as key biomarkers and suggest dovitinib and nintedanib as new targeted therapies ...

The Korea National Institute of Health, under the Korea Disease Control and Prevention Agency, announced on the 17th that it ...

Under the terms of the deal, Gilead will put down $120 million in an upfront payment and will promise up to $1.52 billion in ...

"The longevity gene (LAV-BPIFB4) is the first candidate gene capable of rejuvenating a heart damaged by progeria," added ...

Scientists armed bacteria with cancer-killing viruses that infiltrate tumors, evade immunity, and attack from within.

Researchers create an artificial genetic system mimicking reverse translation, converting music into DNA to explore ...